Emerging Therapeutic Targets in Ovarian Cancer

1. Systemic Therapy for Ovarian Cancer, Current Treatment, Recent Advances, and Unmet Needs
Susana Banerjee, Michael A. Bookman, Martin Gore

2. Discovery of Novel Targets
John Farley, Michael J. Birrer

3. Novel Anti-angiogenic Therapies in Ovarian Cancer
Jurjees Hasan, Gordon Jayson

4. Targeting the AKT Pathway in Ovarian Cancer
Euan A. Stronach, Azadeh Cheraghchi-Bashi, Michelle Chen, Hani Gabra

5. Inhibition of the Src Oncogene: Therapeutic Potential in Ovarian Carcinoma
Liz Y. Han, Anil K. Sood

6. Tumour-Specific Synthetic Lethality: Targeting BRCA Dysfunction in Ovarian Cancer
Timothy A. Yap, Stan H. Kaye, Alan Ashworth, Andrew Tutt

7. Targeting Inflammatory Pathways in Epithelial Ovarian Cancer
Jermaine Coward, Frances Balkwill

8. Epithelial-to-Mesenchymal Transition and Cellular Membrane Receptors in Ovarian Cancer: Moving Forward in the Era of Molecularly Targeted Therapy
Lainie P. Martin, Julia J. Perkins, Russell J. Schilder

9. Epigenetic Therapies
Robert Brown, Nadine Chapman-Rothe, Ros Glasspool

10. Ovarian Cancer Immunology and Immunotherapy
Sadaf Ghaem-Maghami, Martin Gore

11. Ovarian Cancer Progenitor/Stem Cells: Therapeutic Potential
Susan K. Murphy, Andrew Berchuck

12. Potential for α-Folate Receptor-Targeted Treatment for Ovarian Cancer
Chau H.M. Ng, Ann L. Jackman

13. New Insights into Tubulin Binders
Carles Escriu, James D. Brenton

Avainsanat: Biomedicine, Cancer Research, Pharmacology/Toxicology